Skip to main content
. 2019 Dec 11;176(24):4760–4772. doi: 10.1111/bph.14843

Table 4.

Fixed concentrations, EC50s, and αs of propofol with Site 1, 2, and 3 anaesthetics

Drug A [Drug A] μM [Propofol] μΜ α Average α
Etomidate 0.29 ± 0.03 0.158 0.38 ± 0.01
0.25 ± 0.03 0.315 0.61 ± 0.01
0.07 ± 0.02 0.473 0.78 ± 0.01
0.555 0.09 ± 0.01 0.39 ± 0.02
1.11 0.03 ± 0.01 0.54 ± 0.01
1.655 0.01 ± 0.01 0.75 ± 0.01 0.58 ± 0.17 a
R‐mTFD‐MPAB 0.24 ± 0.04 0.158 0.35 ± 0.02
0.14 ± 0.02 0.315 0.56 ± 0.01
0.03 ± 0.01 0.473 0.76 ± 0.01
0.585 0.09 ± 0.01 0.39 ± 0.02
1.17 0.03 ± 0.01 0.54 ± 0.01
1.755 0.01 ± 0.01 0.75 ± 0.01 0.56 ± 0.17 a
Alphaxalone 0.34 ± 0.04 0.158 0.59 ± 0.03
0.29 ± 0.05 0.315 0.79 ± 0.04
0.09 ± 0.01 0.473 0.84 ± 0.01
0.355 0.08 ± 0.02 0.33 ± 0.03
1.710 0.03 ± 0.01 0.53 ± 0.01
1.065 0.03 ± 0.01 0.78 ± 0.01 0.64 ± 0.20 a

Note. α values are reported as ±SD. SD of average αs are Calculated according to Equation (2). Each concentration–response curve had 40 animals except for the first two rows that had 50 and 55 animals respectively.

a

Differs significantly (P < .01) from the value of one expected for additivity.